527 results on '"Halfmann, Peter"'
Search Results
2. Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters
3. Broad protection against clade 1 sarbecoviruses after a single immunization with cocktail spike-protein-nanoparticle vaccine
4. Host range, transmissibility and antigenicity of a pangolin coronavirus
5. Persistent SARS-CoV-2 infection: significance and implications
6. Defining the risk of SARS-CoV-2 variants on immune protection
7. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses
8. Tracing the origin of SARS-CoV-2 omicron-like spike sequences detected in an urban sewershed: a targeted, longitudinal surveillance study of a cryptic wastewater lineage
9. Characterization of SARS-CoV-2 Omicron BA.2.75 clinical isolates
10. Hypergraph Models of Biological Networks to Identify Genes Critical to Pathogenic Viral Response
11. Transmission and re-infection of Omicron variant XBB.1.5 in hamsters
12. Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents
13. Recombinant spike protein vaccines coupled with adjuvants that have different modes of action induce protective immunity against SARS-CoV-2
14. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
15. Characterization of a new SARS-CoV-2 variant that emerged in Brazil
16. Cow’s Milk Containing Avian Influenza A(H5N1) Virus — Heat Inactivation and Infectivity in Mice
17. Comparative analysis of SARS-CoV-2 neutralization titers reveals consistency between human and animal model serum and across assays
18. mRNA-1273 and Ad26.COV2.S vaccines protect against the B.1.621 variant of SARS-CoV-2
19. SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters
20. An infectious SARS-CoV-2 B.1.1.529 Omicron virus escapes neutralization by therapeutic monoclonal antibodies
21. Broadly neutralizing antibodies overcome SARS-CoV-2 Omicron antigenic shift
22. Resilience of S309 and AZD7442 monoclonal antibody treatments against infection by SARS-CoV-2 Omicron lineage strains
23. Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody against antigenically distinct Omicron subvariants
24. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development
25. Protective Immunity and Persistent Lung Sequelae in Domestic Cats after SARS-CoV-2 Infection
26. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection
27. Anti-Ebola virus mAb 3A6 with unprecedented potency protects highly viremic animals from fatal outcome and physically lifts its glycoprotein target from the virion membrane
28. Defining Distinct RNA-Protein Interactomes of SARS-CoV-2 Genomic and Subgenomic RNAs
29. Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine
30. Characterization of highly pathogenic clade 2.3.4.4b H5N1 mink influenza viruses
31. Mapping SARS-CoV-2 antigenic relationships and serological responses
32. Plasma lipidome reveals critical illness and recovery from human Ebola virus disease
33. The Induction of IL-1β Secretion Through the NLRP3 Inflammasome During Ebola Virus Infection
34. Hypergraph models of biological networks to identify genes critical to pathogenic viral response
35. Multivalent nanoparticle-based vaccines protect hamsters against SARS-CoV-2 after a single immunization
36. Defining Distinct RNA-Protein Interactomes of SARS-CoV‑2 Genomic and Subgenomic RNAs.
37. Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection.
38. Comparative Analysis of SARS-CoV-2 Antigenicity across Assays and in Human and Animal Model Sera
39. Ebola Virus Infection Induces HCAR2 Expression Leading to Cell Death
40. An antiviral role for TRIM14 in Ebola virus infection
41. Revealing fine-scale spatiotemporal differences in SARS-CoV-2 introduction and spread
42. Broad Protection Against Clade 1 Sarbecoviruses After a Single Immunization with Cocktail Spike-Protein-Nanoparticle Vaccine
43. Defining distinct RNA-protein interactomes of SARS-CoV-2 genomic and subgenomic RNAs
44. Sensitivity of rapid antigen tests for Omicron subvariants of SARS‐CoV‐2
45. Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate
46. Replicative capacity of SARS-CoV-2 omicron variants BA.5 and BQ.1.1 at elevated temperatures
47. Ebola Virus Stability Under Hospital and Environmental Conditions
48. Characterization and antiviral susceptibility of SARS-CoV-2 Omicron BA.2
49. Pathogenicity and transmissibility of bovine H5N1 influenza virus
50. Identification of interferon-stimulated genes that attenuate Ebola virus infection
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.